Filtered By:
Condition: Diabetes Mellitus
Management: Insurance
Countries: Japan Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 2 results found since Jan 2013.
Comparison of the effects on cardiovascular events between use of metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycaemic agents in Japanese patients with type 2 diabetes mellitus: a claims database analysis
Conclusions
Patients who received metformin as first-line therapy may have reduced cardiovascular events than those receiving DPP-4i. This study conforms to previous Japanese database studies, despite the consideration of its limitation being an observational design.
Source: BMJ Open - March 11, 2022 Category: General Medicine Authors: Nishimura, R., Takeshima, T., Iwasaki, K., Aoi, S. Tags: Open access, Diabetes and Endocrinology Source Type: research
Glucosuria and all-cause mortality among general screening participants
ConclusionDipstick glucosuria significantly affected mortality in Japanese community-based screening participants.
Source: Clinical and Experimental Nephrology - January 12, 2018 Category: Urology & Nephrology Source Type: research